Cell surface CD markers assessment in blood samples
The evaluation of CD3, CD4, and CD8 markers in the AD-MSCs group at different time points had almost the same trend. The levels of cell surface markers in the blood samples of patients receiving AD-MSCs during the 6-month follow-up had a significant reduction (Fig. Cell surface CD marker expression during the 6-month follow-up. 